CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Encrantz Staffan Director | Purchase | +14,100 | $4.88 | $69K | 1,434,283 |
| 2026-06-04 | Encrantz Staffan Director | Grant or award | +28,261 | 1,420,183 | ||
| 2025-12-16 | Encrantz Staffan Director | Purchase | +13,958 | $8.31 | $116K | 1,391,922 |
| 2025-06-06 | Encrantz Staffan Director | Purchase | +27,900 | $4.22 | $118K | 1,377,964 |
| 2025-06-05 | Encrantz Staffan Director | Purchase | +40,951 | $4.24 | $174K | 1,319,112 |
| 2025-06-05 | Encrantz Staffan Director | Grant or award | +30,952 | 1,350,064 | ||
| 2025-06-04 | Encrantz Staffan Director | Purchase | +21,674 | $4.17 | $90K | 1,278,161 |
| 2025-06-03 | Encrantz Staffan Director | Purchase | +25,230 | $3.97 | $100K | 1,256,487 |
| 2025-06-02 | Encrantz Staffan Director | Purchase | +30,799 | $3.88 | $119K | 1,231,257 |
| 2025-05-30 | Encrantz Staffan Director | Purchase | +42,753 | $3.67 | $157K | 1,200,458 |
| 2025-05-29 | Encrantz Staffan Director | Purchase | +60,128 | $3.59 | $216K | 1,157,705 |
| 2025-05-28 | Encrantz Staffan Director | Purchase | +26,715 | $3.52 | $94K | 1,097,577 |
| 2025-05-27 | Encrantz Staffan Director | Purchase | +41,346 | $3.44 | $142K | 1,070,862 |
| 2025-03-12 | Encrantz Staffan Director | Other acquisition | +243,000 | $2.77 | $673K | 5,086,920 |
| 2025-03-11 | Encrantz Staffan Director | Other acquisition | +150,000 | $2.71 | $407K | 4,843,920 |
| 2025-03-10 | Encrantz Staffan Director | Other acquisition | +120,000 | $2.53 | $304K | 4,693,920 |
| 2024-11-21 | Encrantz Staffan Director | Sale | −551,802 | $3.73 | $2.1M | 632,456 |
| 2024-11-21 | Encrantz Staffan Director | Purchase | +551,802 | $3.73 | $2.1M | 4,573,920 |
| 2024-06-06 | Encrantz Staffan Director | Grant or award | +17,366 | 1,029,516 | ||
| 2023-11-30 | Encrantz Staffan Director | Purchase | +140,777 | $3.46 | $487K | 1,012,150 |
Page 1 of 3 · 53 trades